Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...
Serial innovator and entrepreneur’s first published book on the biblical foundation for business is available nowJACKSONVILLE ...